Diagnosing and managing patients with drug hypersensitivity.

Abstract

INTRODUCTION:

Diagnosing and managing drug hypersensitivity is challenging because there are no clear limits between different types of drug reactions. Distinguishing between type A (predictable) and type B (hypersensitivity) reactions when a drug is introduced on the market is not easy. When many people use a drug, adverse reactions can occur, conditioned by diverse genetic profiles, viral infections or concomitant therapy. Occasionally the only tool clinicians have on which to base the diagnosis is the clinical history. Skins tests or in vitro tests sometimes have low sensitivity or are unavailable, and drug provocation tests may be dangerous or strictly forbidden in case of severe cutaneous reactions. Areas covered: This paper reviews the diagnosis and management of the two main types of immunological reactions: IgE-mediated immediate drug hypersensitivity reactions (IDHRs) and non-immediate drug hypersensitivity reactions (NIDHRs). Expert commentary: Although Europe and the United States use different diagnostic methods, patients with history of drug hypersensitivity must avoid the suspicious drug, and clinicians must assess tolerance to safe alternatives under medical surveillance. Sometimes desensitization may be required. There is a consensus about the need to perform genetic testing for specific drugs and give patients proper documentation to prevent future exposure to culprit drugs.

• Authors: Javier Fernandez, Inmaculada Doña
• Journal: Expert review of clinical immunology (Expert Rev Clin Immunol) Vol. 14 Issue 1 Pg. 29-41 (01 2018) ISSN: 1744-8409 [Electronic] England
• PMID: 29202594 (Publication Type: Journal Article, Review, Research Support, Non-U.S. Gov't)

Chemical References

• Allergens
• Anti-Inflammatory Agents, Non-Steroidal
• Immunoglobulin E

Topics

• Allergens (immunology, therapeutic use)
• Anti-Inflammatory Agents, Non-Steroidal (adverse effects)
• Desensitization, Immunologic (methods)
• Drug Hypersensitivity (diagnosis, therapy)
• Europe
• Gene-Environment Interaction
• Genetic Testing
• Humans
• Hypersensitivity, Delayed
• Hypersensitivity, Immediate
• Immunoglobulin E (metabolism)
• Skin (pathology)
• Skin Tests
• United States